Fundraising FoxBiotech Startups
10,841 companies tagged Biotech, with their investors and founders.
Varda industrializes low Earth orbit by manufacturing pharmaceuticals and other specialized products in space, then returning them to Earth via reusable reentry capsules. The company develops both in-space production infrastructure and the vehicles needed to support commercial orbital manufacturing.
36 investors
Neurotechnology company developing implantable brain-computer interfaces for people with paralysis and vision loss.
34 investors
Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology. The company serves biopharma, agritech, and industrial biotech companies seeking to engineer organisms at scale.
31 investors
Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research. The company builds implantable neurotechnology aimed at clinical applications.
30 investors
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum. The company serves oncologists and patients in women's health diagnostics.
29 investors
Solugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale. The company serves customers in energy, chemicals, and related industries with cost-effective alternatives to traditional petrochemical-based manufacturing.
26 investors
Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception. The company works on translational reproductive biology research to bring new contraceptive options to market.
24 investors
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection. The company focuses on making molecular diagnostics accurate, fast, and accessible to patients.
21 investors
Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
21 investors
Science Corporation develops brain-computer interface and neural engineering technology to restore vision, cognition, and mobility to patients with debilitating conditions. The company also provides components and vertically integrated infrastructure through Science Foundry to support innovation across the neural technology industry.
21 investors
23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery. The company enables individuals to learn about their genetic traits while contributing to medical research studies that benefit public health.
20 investors
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions. The company was founded in 2025 through a strategic combination of atai Life Sciences and Beckley Psytech.
20 investors
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.
20 investors
Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools. It serves scientists and biotech R&D teams working with biomolecules, small molecules, cell lines, and other research data.
19 investors
Geltor uses a proprietary biodesign and precision fermentation platform to create and commercially produce novel protein ingredients, including collagens, for beauty and personal care formulators. Its process spans computational protein design, large-scale fermentation, purification, and claims substantiation to deliver animal-free, GMO-free protein ingredients.
19 investors
Genesis develops GEMS, an AI platform for drug discovery that identifies and optimizes drug candidates. The company partners with pharmaceutical firms like Incyte and Gilead to accelerate the identification and optimization of new drugs.
19 investors
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management. The company's pipeline spans depression, anxiety, addiction, and schizophrenia, with programs validated by AbbVie's acquisition of its first asset and partnerships with Columbia University and the National Institute on Drug Abuse.
19 investors
Loyal develops longevity drugs for dogs, targeting the biological processes of aging to extend healthy lifespan and reduce age-associated disease. Its lead drug candidate, LOY-002, is a once-daily pill for senior dogs that addresses metabolic dysfunction and is progressing through FDA conditional approval, alongside a broader portfolio of aging therapeutics and educational resources for veterinarians.
19 investors
Upside Foods produces cultivated meat using cell-based technology. The company serves consumers and food companies seeking alternative protein sources in the meat industry.
19 investors
Enveda operates a drug-discovery platform that analyzes natural samples—primarily plant-derived molecules—using mass spectrometry, AI foundation models, and automated high-throughput labs to identify their chemical structures and therapeutic properties. The company maintains a searchable library of plant molecules to find new medicines and applies its technology toward human and planetary health challenges.
18 investors
Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes. The company uses stem cell biology and in vitro maturation techniques to create innovative solutions for patients seeking family-building options.
18 investors
Iterative Health is a healthcare technology and services company that combines clinical trial expertise with AI to help research teams and study sponsors expand and speed up patients' access to novel therapeutics. It partners with providers and study sponsors to support clinical research infrastructure, particularly in gastroenterology and community care settings.
18 investors
BlueNalu develops cell-cultivated seafood grown directly from fish cells in a controlled environment, aiming to supply seafood without harvesting it from the ocean. The company positions its products as an alternative to traditional fisheries to address global seafood supply gaps.
17 investors
MycoTechnology develops food and beverage ingredients using mushroom mycelial fermentation, creating flavor modulation and sugar-reduction solutions for formulators, chefs, and R&D professionals. Founded in 2013, the company focuses on cleaner-label, better-tasting ingredients for the food industry.
17 investors